Patients and methods
Reactive arthritis, a sterile joint inflammation preceded by an infection elsewhere in the body, may be triggered by an enteric or urogenital infection. The microbes triggering reactive arthritis include yersinia, salmonella, shigella, campylobacter, chlamydia, and possibly gono-COCCUS. l2 The acute reactive arthritis is characterised by inflammatory signs that are both local (synovitis with polymorphonuclear cells predominating in the synovial fluid) and systemic (fever, conjunctivitis, iritis, urethritis, and mucocutaneous symptoms).
Peripheral blood polymorphonuclear leucocytes (PMN) of HLA-B27 positive patients with yersinia arthritis show increased chemotaxis,3 and PMN of patients who had recovered from a severe acute disease4 or those who have inflammatory sequelae5 tend to show enhanced chemiluminescence, suggesting that the cells are primed-that is, rendered hyperreactivefor instance, by mediators of inflammation.67 Chemotaxis of the peripheral blood PMN of patients with rheumatoid arthritis is depressed8 9 or normal,,'0 " and superoxide production is enhanced. 12 Synovial fluid PMN, however, show depressed chemotaxis13 and depressed chemiluminescence responses. '4 This indicates that the synovial fluid cells in rheumatoid arthritis tend to be deactivated for both chemotaxis and production of oxygen 
Results

CHEMOTAXIS
At the acute phase of the disease the synovial fluid PMN, tested by the agarose assay, showed significantly decreased migration in response to ZTS and FMLP (chemotaxis) and also in ZTS and in FMLP (chemokinesis), whereas spontaneous migration towards HBSS was not affected (fig 1) . Also, in the filter assay, synovial fluid PMN tended to show depressed chemotaxis and chemokinesis, though the difference was statistically significant only in the study of migration towards ZTS (fig 2) . The rates of migration of the peripheral blood PMN were very similar to those of the control PMN in both assays (figs 1 and 2). The patients' peripheral PMN had, however, a decreased chemokinetic migration under agarose in ZTS. At one month both the chemotactic and chemokinetic migration rates of the patients' PMN and the control PMN were much the same, whereas the spontaneous migration of the patients' PMN under agarose, but not in the filter, was decreased (table 2) .
At six months after recovery, the chemokinetic and chemotactic responses of the patients' PMN to ZTS were in the agarose assay significantly lower and in the membrane filter technique significantly higher than those of the control PMN (table 2) .
CHEMILUMINESCENCE
At the acute phase the peak chemiluminescence response of the synovial PMN to opsonised zymosan particles was significantly lower than that of control PMN (fig 3) . The response to phorbol myristate acetate, but not to FMLP, also tended to be decreased, though not significantly (fig 3) . The responses of the patients' peripheral blood PMN and control PMN were much the same at the acute phase, at one month, and at six months ( fig 3 and table 2 ). The shapes of the chemiluminescence curves of the three groups were similar and analysis of the areas under the curves showed findings identical to the peak responses (data not shown). Discussion These findings indicate that chemotactic and chemokinetic migration of synovial fluid PMN of patients with acute reactive arthritis is depressed, and oxygen radical production determined by the luminol enhanced chemiluminescence assay is also depressed or similar to that of peripheral blood PMN of the patients and healthy control subjects. These functional aberrations suggest that the patients' synovial fluid PMN are deactivated. 6 Deactivation of synovial fluid PMN occurs in patients with rheumatoid arthritis,'3 14 possibly owing to the ingestion of immune complexes by PMN. Under experimental conditions PMN exposed to small size aggregated IgG show decreased stimulated migration20 and decreased chemiluminescence responses,21 22 whereas large aggregates are stimulatory.20 Some patients with yersinia arthritis have circulating yersinia specific immune complexes of small size23 and also yersinia specific immune complexes in synovial fluid. 24 The presence of microbial structures in the joint fluid is further supported by the finding ofchlamydia and yersinia antigens in the synovial fluid cells of patients with reactive arthritis triggered by chlamydia urethritis25 and yersinia enteritis.26 Thus deactivation is a characteristic of synovial fluid PMN in both rheumatoid arthritis'3 14 and seronegative reactive arthritis as shown in this study and, possibly, immune complexes contribute to both disorders.
The mechanism of deactivation is not known but it may entail auto-oxidation of PMN; this is supported by the findings that oxygen radical scavengers potentiate chemotaxis27 and that PMN of patients with chronic granulomatous disease, which cannot generate oxygen radicals, do not become deactivated.28 It is also possible that the non-steroidal anti-inflammatory drugs taken by our patients may inhibit chemotaxis29 and production of oxygen derived free radicals. '2 30-32 This explanation is not supported by the finding that the patients' peripheral blood PMN were functionally normal and not deactivated.
In this study chemotactic/chemokinetic migration of the patients' purified peripheral blood PMN was similar to that of control PMN during the acute disease, whereas after recovery the chemokinetic responses of the patients' PMN to ZTS were depressed in the agarose assay and increased in the filter assay. These findings differ from those in our previous study,3 which showed that both at the acute phase and after recovery buffy coat PMN of HLA-B27 positive patients with yersinia arthritis showed increased migration in response to ZTS. Buffy coat does also contain monocytes which increase migration of PMN 
